Nigerians are eagerly seeking Lenacapavir, a newly introduced injection for preventing Human Immunodeficiency Virus, ahead of its nationwide rollout.
Many individuals, particularly those familiar with pre-exposure prophylaxis, have been visiting health facilities and non-governmental organisations across various states in an attempt to access the injection.
The Federal Government has begun deploying the twice-yearly HIV prevention medication in selected pilot states, with the rollout expected to begin on March 24.
Lenacapavir is a twice-yearly injectable HIV pre-exposure prophylaxis drug developed by Gilead Sciences and recommended by the World Health Organisation as an additional PrEP option.
It offers a long-acting alternative to daily HIV prevention pills and has been endorsed by the WHO as part of a broader global HIV prevention strategy.
According to estimates, there are approximately two million people living with HIV/AIDS in Nigeria.
The Federal Government has received 52,000 doses of the injection, with 11,520 already delivered.
The National Agency for the Control of AIDS and its partners are working to ensure the safe introduction and effective integration of Lenacapavir into national HIV prevention options.
Health workers are currently undergoing training on standard procedures for administering the PrEP, and the injection will be administered at designated health centres.
The Federal Government's decision to roll out Lenacapavir nationwide is a welcome development, particularly for those living with HIV/AIDS. However, the high demand for the injection in states like Osun, Anambra, and Benue raises concerns about the preparedness of our healthcare system. The National Agency for the Control of AIDS must ensure that the rollout is well-coordinated and that health workers are adequately trained to administer the PrEP. The government must also address the issue of accessibility, particularly in areas where the injection is not yet available in pharmacies. This is a critical moment for Nigeria's HIV prevention efforts, and we must get it right.
